Time restricted eating facilitates weight loss and improves cardiometabolic profile in a female veteran with multiple sclerosis: A case report

The Journal of Spinal Cord Medicine, 2023 · DOI: 10.1080/10790268.2022.2163136 · Published: January 1, 2023

Simple Explanation

A female veteran with multiple sclerosis and spinal cord involvement used time-restricted eating (TRE) to counteract weight gain. TRE involves eating all calories within a specific daily window. In this case, the patient ate all calories within a 6-hour window. The patient experienced weight loss and improvements in cardiometabolic markers after implementing TRE.

Study Duration

6 Months

Participants

One 56 year old female veteran with relapsing-remitting multiple sclerosis

Evidence Level

Level 4; Case Report

Key Findings

1
The patient experienced significant weight loss (7.2 kg based on self-report, 9.5 kg from 1 year prior based on Veterans Affairs (VA) measurements).
2
Her BMI approached normal (BMI 25.5, weight 65.3 kg).
3
Her cardiometabolic markers improved as she went from prediabetic to normoglycemic.

Research Summary

A 56-year-old female veteran with multiple sclerosis (MS) implemented a time-restricted eating (TRE) program, eating all calories within a 6-hour window, to combat weight gain. Over 6 months, the patient experienced significant weight loss, her BMI approached normal, and her cardiometabolic markers improved from prediabetic to normoglycemic. The veteran reported an improved motivation for reducing her sugar, soda, and carbohydrate intake with TRE, and found it easier to implement these changes.

Practical Implications

Weight Management Strategy

TRE may be a feasible weight management option for individuals with MS and SCI.

Cardiometabolic Improvement

TRE can lead to improvements in cardiometabolic markers, such as HbA1c, cholesterol, and triglycerides.

Quality of Life

TRE may improve emotional, behavioral, and physical quality of life.

Study Limitations

1
Single case study limits generalizability.
2
Self-reported data may be subject to bias.
3
Long-term efficacy and safety of TRE are not clear.

Your Feedback

Was this summary helpful?

Back to Neurology